上海
*仅供医学专业人士阅读参考
关于罗泽利昔珠单抗的给药方法你了解多少？
*以下内容仅供在中国大陆执业的
医疗卫生专业人士浏览。
参考文献：
[1]常婷. 中国重症肌无力诊断和治疗指南(2020版)[J]. 中国神经免疫学和神经病学杂志, 2021,28(01):1-12.
[2]常婷,李柱一.重症肌无力的治疗:期待靶向免疫治疗时代的到来[J].中华神经科杂志,2022,55(4):271-279.
[3]Roopenian DC, Akilesh S. FcRn: the neonatal Fc receptor comes of age[J]. Nat Rev Immunol. 2007 Sep;7(9):715-25.
[4]Patel DD, Bussel JB. Neonatal Fc receptor in human immunity: Function and role in therapeutic intervention[J]. J Allergy Clin Immunol. 2020 Sep;146(3):467-478.
[5]Smith B, Kiessling A, Lledo-Garcia R, et al. Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration[J]. MAbs. 2018 Oct;10(7):1111-1130.
[6]Bril V, Drużdż A, Grosskreutz J, et al.Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study[J]. Lancet Neurol. 2023 May;22(5):383-394.
文章审批码 CN-RZ-2500039
有效期 2027年5月
*此文仅用于向医学人士提供科学信息，不代表本平台观点
特别声明：以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布，本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
